ASK1-IN-1, 99%

ASK IN 1

APTO-253, ≥99%

APTO-253

6β-羟基雌酮

6Beta-hydroxyestrone

9-甲氧基喜树碱, ≥99%(HPLC)

9-Methoxycamptothecin

1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基)-2-苯基乙烷-1,2-二酮, 99%

1-(7-Methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)-2-phenylethane-1,2-dione

4-氯苯并[f]异喹啉

4-Chlorobenzo[f]isoquinoline

>98%

7-苄基-4-氯-7H-吡咯并[2,3-D]嘧啶, ≥98%

7-Benzyl-4-chloro-7H-pyrrolo[2,3-d] pyrimidine

PTZ-343, 99%

PTZ-343

(S)-2-((1R,2R)-3-(((1S,2R)-1-羟基-1-苯丙烷-2-基)氨基)-1-甲氧基-2-甲基-3-氧代丙基)吡咯烷-1-羧酸叔丁酯, 99%

(S)-tert-Butyl 2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate

N-[（（5-氨基-1-苯基-1H-吡唑-4-基）-羰基]乙基肼基甲酸乙酯

Ethyl N-[(5-amino-1-phenyl-1H-pyrazol-4-yl)-carbonyl]ethanehydrazonoate

（7α，8β，9α，10α）-7,8,9,10-四氢苯并[a]芘-7,8,9,10-四醇

(7α,8β,9α,10α)-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol

14,15-白三烯C4（毒素 C4）

14,15-Leukotriene C4 (eoxin C4)

≥99%

Lanraplenib (GS-9876), 99%

ENOblock

S-（2,3,4-三羟基丁基）巯基酸

(2R)-2-acetamido-3-(2,3,4-trihydroxybutylsulfanyl)propanoic acid

1-十三炔

1-Tridecyne

98%

尿苷基（3'5'）尿苷铵盐

Uridylyl(3′ 5′)uridine ammonium salt

CD38 inhibitor 78c, 99%

CD38 inhibitor 78c

2-氨基-3,5-二溴苄醇, ≥98%

(2-Amino-3,5-dibromophenyl)methanol

7-氨基-3-氯-3-头孢环-4-羧酸, 96%

(6R,7R)-7-Amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

乙基 8-[4-[8-(1,4-二恶-8-氮杂螺-[4.5]癸基)甲基]苯基]-8-羰基辛酸酯, 98%

ethyl 8-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate